Estrogen downregulates TAK1 expression in human fibroblast‑like synoviocytes and in a rheumatoid arthritis model

Corrigendum in: /10.3892/etm.2022.11149

  • Authors:
    • Xi Li
    • Miao Li
  • View Affiliations

  • Published online on: June 5, 2020     https://doi.org/10.3892/etm.2020.8848
  • Pages: 1764-1769
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Transforming growth factor β‑activated kinase‑1 (TAK1), a member of the mitogen‑activated protein kinase family, plays a key role in the pathogenesis and progression of rheumatoid arthritis (RA). Estrogen has been previously reported to delay arthritis progression. However, the exact association between TAK1 and estrogen remains elusive. The present study demonstrated that TAK1 was upregulated in synoviocytes of patients with RA compared with patients with osteoarthritis and healthy controls. In addition, TAK1 was also expressed in cultured fibroblast‑like synoviocytes (FLS), and its levels decreased significantly in 17β‑estradiol (E2)‑treated cells in a dose‑dependent manner. Furthermore, administration of E2 significantly decreased TAK1 expression and attenuated the development of collagen‑induced arthritis (CIA). Taken together, the findings of the present study suggested that E2 mediates a decrease of TAK1 in both FLS and CIA, which subsequently results in a suppression of the pathological process of CIA. Therefore, estrogen may serve as a potential therapeutic agent for the treatment of RA by targeting TAK1.
View Figures
View References

Related Articles

Journal Cover

August-2020
Volume 20 Issue 2

Print ISSN: 1792-0981
Online ISSN:1792-1015

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Li X and Li X: Estrogen downregulates TAK1 expression in human fibroblast‑like synoviocytes and in a rheumatoid arthritis model Corrigendum in /10.3892/etm.2022.11149. Exp Ther Med 20: 1764-1769, 2020
APA
Li, X., & Li, X. (2020). Estrogen downregulates TAK1 expression in human fibroblast‑like synoviocytes and in a rheumatoid arthritis model Corrigendum in /10.3892/etm.2022.11149. Experimental and Therapeutic Medicine, 20, 1764-1769. https://doi.org/10.3892/etm.2020.8848
MLA
Li, X., Li, M."Estrogen downregulates TAK1 expression in human fibroblast‑like synoviocytes and in a rheumatoid arthritis model Corrigendum in /10.3892/etm.2022.11149". Experimental and Therapeutic Medicine 20.2 (2020): 1764-1769.
Chicago
Li, X., Li, M."Estrogen downregulates TAK1 expression in human fibroblast‑like synoviocytes and in a rheumatoid arthritis model Corrigendum in /10.3892/etm.2022.11149". Experimental and Therapeutic Medicine 20, no. 2 (2020): 1764-1769. https://doi.org/10.3892/etm.2020.8848